Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Powder pharmaceutical formulations for treating infantile diarrhea

A technology for infantile diarrhea and medicine, applied in the field of pharmaceutical powder for the treatment of infantile diarrhea, can solve the problems of difficult to prescribe the right medicine and high cost of treatment, and achieve the effect of regulating the stomach and stopping diarrhea quickly

Inactive Publication Date: 2009-10-07
杨国强
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Diarrhea in children caused by indigestion or other reasons, watery diarrhea, egg-like diarrhea, green stools, etc. There are various drugs and methods to treat this disease, but some treatments are expensive, and some are difficult. Prescribe the right medicine to bring pain to the patient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1, the present invention is made of lactase 0.1--1g, compound diphenoxylate 0.25-2.5mg, acetylsalicylic acid 0.3-0.15g, chlorpheniramine 0.04-0.2mg and hydrochlorothiazide tablet 1- - 5mg is made, the above medicines are co-researched into fine powder and can be measured and packaged.

Embodiment 2

[0013] Embodiment 2, the present invention is produced by lactase 0.3-0.7g, compound diphenoxylate 0.75-2mg, acetylsalicylic acid 0.8-0.10g, chlorpheniramine 0.08-0.16mg and hydrochlorothiazide tablet 1- - 5mg is made, the above medicines are co-researched into fine powder and can be measured and packaged.

Embodiment 3

[0014] Embodiment 3, the present invention is produced by lactase 0.1-1g, compound diphenoxylate 1.25-1.5mg, acetylsalicylic acid 0.8-0.10g, chlorpheniramine 0.040.2mg and hydrochlorothiazide tablet 1-5mg If it is made, the co-researched fine powder of the above medicines can be measured and packaged.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a powder pharmaceutical formulations for treating infantile diarrhea which overcomes weak pocket of other medicament for treating the disease. The powder pharmaceutical formulation is prepared by raw materials as follows: biofermin 0.1-1 g, compound diphenoxylate 0.25-2.5 mg, acetylsalicylic acid 0.3-0.15 g, chlorphenamine 0.04-0.2 mg and hydrochlorothiazidum tablet 1-5 mg, the above medicine are grinded to dead small, then are measured and packed for obtaining the powder pharmaceutical formulation. The powder pharmaceutical formulation for treating infantile diarrhea is used about twenty years and is consulted by patients 10000 times, wherein, males 5500 times, females 4500 times, curative rate 98% and efficiency rate 100%.

Description

1. Technical field: [0001] The invention relates to a medicine for treating diarrhea in children, in particular to a medicine powder for treating diarrhea in children. 2. Background technology: [0002] Diarrhea in children caused by indigestion or other reasons, watery diarrhea, egg-like diarrhea, green stools, etc. There are various drugs and methods to treat this disease, but some treatments are expensive, and some are difficult. Prescribe the right medicine and bring pain to the patient. 3. Contents of the invention: [0003] The purpose of this invention is to provide a kind of medicine powder for the treatment of infantile diarrhea with simple treatment method and low treatment cost, which overcomes the shortcomings of other medicines for treating this disease. 0.1-1g of raw material, 0.25-2.5mg of compound diphenoxylate, 0.3-0.15g of acetylsalicylic acid, 0.04-0.2mg of chlorpheniramine and 1-5mg of hydrochlorothiazide tablet. Grind into fine powder and measure and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/74A61P1/12A61K31/4402A61K31/451A61K31/549A61K31/616A61K35/744
Inventor 杨国强
Owner 杨国强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com